Executive Summary12-Test Clinical Matrix
Executive Summary • Clinical Decision Matrix

Intended Use of Biomarkers and Diagnostic Tests for MASH

Mapping 12 blood, imaging, and composite diagnostic tools to their primary clinical applications and required data inputs.

What This Means for Patients

If you're wondering why your doctor ordered two or three different tests instead of just one, this chart shows how the pieces fit together. Tests at the top (FIB-4 and SAFE) act as an early triage screen, middle groups measure either liver fat or scar stiffness individually, and the bottom group assesses both fat and scarring together.

Test-Type Legend

Calculation Imaging-based Laboratory-based Clinical dataa
Intended Use Biomarker / Diagnostic Test Test Type Components
Referral / risk stratification FIB-41-4
CalculationLaboratory-basedClinical dataa
SAFE score5
CalculationLaboratory-basedClinical dataa
Steatosis assessment only Ultrasound attenuation6
Imaging-based
MRI-PDFF3
Imaging-based
Fibrosis assessment only ELF™1,2
CalculationLaboratory-based
US-based elastography1,7
Imaging-based
MRE2
Imaging-based
Agile 3+ / Agile 48
CalculationImaging-basedLaboratory-basedClinical dataa
Steatosis and fibrosis assessment NASH-FibroSure® / FibroTest™9-11
CalculationLaboratory-basedClinical dataa
LiverMultiScan12
Imaging-based
FAST13,14
CalculationImaging-basedLaboratory-based
MAST14
CalculationImaging-basedLaboratory-based